HTG Molecular

$4.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.44 (+10.21%) Today
-$0.14 (-2.97%) As of 5:49 PM EST after-hours

Why Robinhood?

You can buy or sell HTG Molecular and other stocks, options, and ETFs commission-free!

About HTGM

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It offers instruments, reagents and services for molecular profiling applications. The firm serves biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ. The listed name for HTGM is HTG Molecular Diagnostics, Inc. Common Stock.

CEO
John L. Lubniewski
Employees
112
Headquarters
Tucson, Arizona
Founded
1997
Market Cap
334.86M
Price-Earnings Ratio
Dividend Yield
Average Volume
244.88K
High Today
$4.76
Low Today
$3.78
Open Price
$3.84
Volume
743.17K
52 Week High
$4.76
52 Week Low
$0.2671

Collections

HTGM Earnings

-$0.20
-$0.14
-$0.07
-$0.01
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.08 per share
Actual
-$0.07 per share

You May Also Like